Daniel M. Keller, PhD, Author at Renal and Urology News

Daniel M. Keller, PhD

All articles by Daniel M. Keller, PhD

Short-Course Rituximab Produces Long-Term Remissions of ANCA Vasculitis

PRAGUE—A single four-week course of rituximab was as effective as 18 months of standard therapy with daily oral cyclophosphamide (CyP) and azathioprine (AZA) for induction and maintenance of remission in patients with severe anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). For either treatment, the number, rate, and severity of adverse events did not differ.

Next post in ERA-EDTA Congress